The specifics, since they change the answer: VendorInvestigate · QYB.
I would like to know the limits of what can be inferred from this.
What I am trying to avoid is over-reading a single result, which I have done before.
What can I legitimately conclude from this figure?
The short answer is that VendorInvestigate is expensive because they do thorough testing, but the cost is paid once per supplier rather than per lot.
Reports include the dates of testing and the lot numbers of the tested material, tying the result to specific material.
Analytical data are published in full, including HPLC traces, mass spectra and quantitation details.
The service has been operating long enough that systematic bias in their testing would be apparent.
Coverage is not comprehensive — only vendors that enough people choose to test are in the database.
Favorable reports are valuable and should increase your confidence in a vendor.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsUse VendorInvestigate data before committing to a new supplier, because the independent verification is worth the time to read.
Cost per test is higher than for Janoshik or Medutest, but coverage of multiple vendors is cheaper than testing everyone yourself.
VendorInvestigate accepts customer submissions of material for independent testing, with full anonymity protected.
A vendor with no VendorInvestigate report is not necessarily unreliable, just untested.
Check VendorInvestigate before choosing a new supplier.
The reports are free to read, but the testing itself costs money, so coverage is not complete — only suppliers that enough people care about are fully tested.
The database is searchable by vendor, compound, date and result, and historical trends are visible.
The underlying point is that unfavorable reports are important — they flag problems that should affect your supplier decision.
VendorInvestigate reports are submitted through formal channels and involve independent verification before publishing.
Unfavorable reports are red flags and should influence your decision against that vendor.
The testing is submitted by customers, not by suppliers, so the reports are independent evidence of what the supplier actually delivers.
Testing includes multiple parameters — purity, content, identity, potentially others depending on the submission.
Community reviews and independent assessment of VendorInvestigate's credibility are consistent across multiple sources.
If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.
A vendor with a recent favorable VendorInvestigate report has earned credibility, and a vendor with an unfavorable report is a red flag.
Favorable reports are usually not surprising, but they provide credible confirmation of what the supplier claims.
The ICH Q3A and Q3B thresholds for reporting, identification and qualification of impurities are the framework the pharmaceutical industry works to, and they are worth reading even though nothing in the research-grade supply chain is obliged to meet them, because they tell you which numbers a competent analyst would consider worth reporting at all.
In practice: ask for the chromatogram, check the method section, check the lot number against the vial, and set your accept threshold before you see the result rather than after.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.